CD2
dim surface markers and are distinguishable from T cells by the lack of rearranged TCR genes. Unlike B cells, NK cells do not express surface Ig (1) .
In addition to their cytotoxic activity, NK cells participate either directly or indirectly in multiple developmental and regulatory aspects of the immune system characterized by rapid response to exogenous and endogenous signals by producing a variety of cytokines and chemokines (2) (3) (4) .
The ability of NK cells to produce hemopoietic cell growth factors, IFN, IL, TNF ␣ and ␤, TGF, and other growth factors, combined with their ability to respond rapidly to exogenous signals by up-regulating mRNA expression for various cytokines within minutes demonstrates the importance of NK cells as mediators or effectors of the intercellular communication network (reviewed in Ref. 2) .
Under activated conditions, NK cells express and up-regulate the receptors for a variety of chemotactic factors, cytokines, growth factors, and hormones including the expression of the ligand of the CD40 receptor (CD154) thus enhancing NK cell interactions within the immune system. For example, it has been shown that NK cells are involved in the regulation of B lymphocyte functions (5) (6) (7) (8) . Donor type-activated NK cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation in mice (9) and in humans (10) . Also, human NK cells can enhance the B cell proliferative responses to the surface Ig cross-linking agents anti-IgM or Staphylococcus aureus Cowan strain (6) .
By direct interaction between B cells and NK cells, it has been shown that B cells are able to stimulate the production of IFN-␥ by NK cells and activation of the NK cells (11) . Thus, both B cells and NK cells are capable of interacting in a spontaneous manner leading to a costimulatory effect.
The evidence described above suggests that NK cells are involved in B cell maturation, Ig secretion, and isotype switching, pathways well-known to be regulated by CD40-CD154 interaction (12) . The absence, or blockade, of the CD40-CD154 interaction results in gross impairment of the B cell physiological and molecular pathways that seem to be unique to the T-dependent Ab response.
Whether the CD40-CD154 engagement plays a role in B cell regulation by NK cells remains to be clarified. The expression of mRNA for CD40 ligand (CD40L) 2 on purified NK cells has been reported previously (13) ; more recently, a role for CD40-CD154 in NK cell interaction with other cells has been described (14) . NK cell clones expressing CD154 were able to kill target cells expressing CD40 receptors. Although freshly isolated human NK cells were unable to lyse CD40 ϩ targets, when activated with rIL-2 they were able to kill the CD40-transfected cells. This study also reported that coexpression of CD40 and MHC class I Ag on the target cell inhibited the lysis by the NK cells, suggesting a regulatory role of MHC class I in the CD40-triggered killing.
Direct interaction between B and NK cells under activated conditions are supported by several studies, particularly in mouse models (15) (16) (17) (18) . Evidence from human studies suggests that NK cells and B cells can spontaneously interact in vitro, as demonstrated by conjugate formation and activation of the interacting cells (11) . However, this activating function is poorly understood.
NK cells are potent regulatory cells in the innate immune system, characterized by their spontaneous interaction with immune and nonimmune cells (11, 19) . In addition, growing evidence suggests that NK cells might be involved in the development of autoimmune diseases (20) . However, the mechanisms by which NK cells modulate these responses are not entirely clear. In this study, we tested the hypothesis that spontaneous interaction between human B cells and autologous NK cells might be important in initiating the innate B cell response which, under the appropriate conditions, might provide an early protective advantage to the host or contribute to the development of autoimmunity.
Materials and Methods

Reagents
RPMI 1640 culture medium and Dulbecco's PBS, L-glutamine, and penicillin-streptomycin were purchased from BioWhittaker (Walkersville, MD); FBSЈ was purchased from Biofluids (Rockville, MD). Lymphocyte separation medium and BSA were obtained from ICN Pharmaceuticals (Aurora, OH). Percoll was obtained from Amersham Pharmacia Biotech (Upsala, Sweden); polyoxyethylene-sorbitan monolaurate (Tween 20) was obtained from Sigma-Aldrich (St. Louis, MO). ELISA kits for human TNF␣, IL-6, IL-4, IFN-␥, and IL-10 quantification were obtained from R&D Systems (Minneapolis, MN).
Monoclonal and polyclonal Abs
Anti-CD3 FITC, anti-CD19 PE, anti-CD14 FITC, anti-CD56 PE, anti-CD5 FITC, anti-CD40 PE, anti-CD40L (anti-CD154) PE, anti-CD27 FITC, antiIgM FITC, anti-IgG, IgD, and anti-CD27 FITC mAbs were purchased from BD Biosciences (San Jose, CA). Anti-CD56 microbeads (CD56 beads) and streptavidin microbeads were obtained from Miltenyi Biotec (Oslo, Sweden). CD40-muIg fusion protein was obtained from Ancell (Bayport, MN).
Lymphocyte preparation
PBMC were isolated from the buffy coats of healthy donors (obtained from the National Institutes of Health blood bank) after centrifugation on a lymphocyte separation medium. Cells were washed twice with Dulbecco's PBS and suspended in RPMI 1640 medium supplemented with 2 mM of L-glutamine, 100 IU/ml penicillin, 50 g/ml streptomycin, and 10% FCS. Adherent cells were removed by incubation in plastic flasks for 1 h at 37°C and the nonadherent cells were recovered by being gently washed with warmed medium and incubated on nylon wool columns for 1 h at 37°C. The nylon nonadherent cells (mostly T cells and NK cells) were eluted with prewarmed RPMI 1640 medium and the nylon adherent cells (enriched B cell fraction) were recovered by washing and soaking the nylon wool with cold PBS plus 1 mM of EDTA.
Cell fractionation by Percoll gradient
Both nylon adherent (B enriched fraction) and nonadherent cells (T cells plus NK cells) were fractionated separately on a seven-step Percoll gradient as previously described (21) . High-density fractions (F4 to F6) from the nylon adherent cell gradients containing 60 -80% resting B cells were used for further purification of B cells and the low density fraction 2 from the nonadherent cell gradients (40 -60% NK cells) was used to purify NK cells. Fraction 5 from the NK cell gradient (96 Ϯ 2% CD3 ϩ T cells) was used as the source of T cells.
Purification of B cells and NK cells by magnetic columns
B cells and NK cells obtained by Percoll gradient centrifugation were further depleted from the remaining T lymphocytes and monocytes by negative selection with anti-CD3 and anti-CD14 mAbs. The cells were labeled for 30 min on ice with biotinylated anti-CD3 and anti-CD14. After removing the unbound Abs by washing with cold PBS plus 1% BSA, the cells were incubated for 15 
In vitro assay for B cell activation with NK cells
Highly purified B lymphocytes (1 ϫ 10 6 cells/ml) were mixed at different ratios with autologous NK cells or T lymphocytes in 1.5-ml polystyrene microcentrifuge tubes (Fisher Scientific, Pittsburgh, PA). The cell suspension was centrifuged at 200 ϫ g for 10 s in a microcentrifuge (Capsule; Tomy, Tokyo, Japan) and incubated for 5 min at 37°C in a water bath. Then, cell mixtures were immediately transferred to an ice bath. These conditions were previously determined as the minimum time necessary to activate the B cells with the NK cells as evaluated by tyrosine-phosphorylation studies (data not shown). In some experiments, the cell mixture was only desegregated and the B cell concentration was adjusted to 5 ϫ 10 5 cells/ml in RPMI 1640 plus 10% FCS (complete medium) and cultured for 6 days at 37°C in an atmosphere of 5% CO 2 . In other experiments, the stimulating T cells or NK cells were removed from the mixture by magnetic columns (as described above) after labeling at 4°C with biotinylated anti-CD3 plus streptavidin microbeads or anti-CD56 microbeads, respectively. The remaining B cells stimulated with T cells (BsT cells) or with NK cells (BsNK cells) contained Ͻ2% of T cells or NK cells as determined by flow cytometry using double-labeling with anti-CD5 FITC/anti-CD19 PE and anti-CD19 FITC/CD16 PE, respectively. Both BsT cells and BsNK cells were adjusted to 5 ϫ 10 5 cells/ml and cultured for 6 days in the same conditions as above. Each culture was performed in triplicate in 1 ml of medium using 12 ϫ 75 round-bottom sterile culture tubes (BD Biosciences). Finally, the cell cultures were centrifuged at 1200 ϫ g for 10 min and the cell-free supernatants were harvested, filtered through a 0.22 m Millipore filter (Bedford, MA), and tested for secreted Ig.
Fixation of NK cells
In some experiments, the NK cells were fixed for 5 min with 1% glutaraldehyde, washed three times with PBS, rested for 1 h at room temperature (RT) to achieve polymerization of the fixative, and suspended in RPMI 1640 plus 10% FCS before use for B cell stimulation.
Ig analysis
Quantitation of IgM, IgG, and IgA in cell-free supernatants was performed by an ELISA specific for human IgM, IgG, and IgA (Bethyl Laboratories, Montgomery, TX). Nun Maxisorp C bottom-well plates (Nunc, Naperville, IL) were coated with isotype-specific capture Abs at 1 g/well in 0.1 ml of 0.5 M sodium carbonate (pH 9.6) for 1 h at RT. The plates were washed twice with a wash solution containing 50 mM of Tris (pH 8.0), 0.1 M of NaCl, and 0.05% Tween 20 and incubated for 30 min at RT with a postcoat solution (1% BSA in 50 mM of Tris (pH 8.0), 0.15 M of NaCl) to block nonspecific binding. Subsequently, cell-free supernatants and standards (reference serum or calibrator) were added in duplicate to the plate wells (100 l/well). Dilution of the standards was made in a blocking solution to avoid binding of serum components to the wells. All plates were incubated for 1 h at RT, washed three times with wash solution, and incubated 1 h at RT with 100 l/well optimal concentration of isotype-specific (anti-human IgM, IgG, and IgA) Abs conjugated with HRP. After washing three times, the enzyme substrate hydrogen peroxide plus 3,3Ј,5,5Ј-tetramethylbenzidine was added for 20 min at RT in the dark and the reaction was stopped with 50 l of 2 M of H 2 SO 4 . Plates were read in a MRX microplate reader (Dynatech Laboratories, Chantilly, VA) and isotype concentrations were extrapolated from a reference curve (range: 500 -7.5 ng/ml of the corresponding isotype). A revelation program incorporated with the microplate reader (revelation program, Dynatech) calculated the Ig concentration.
Results
NK cell activation of autologous B cells
Previous reports (11, 22) To place this response in the context of a mitogen-stimulated B cell response, we have also evaluated the activation of the B cells by NK cells in combination with PWM or IL-2 ( Table I ). The data demonstrate that the response of the B cells to stimulation with NK ϩ PWM is over 40-fold for IgM and IgG in both unfractionated B cells and high-density B cells. However, when we compare the Ig synthesis induced by NK cells alone with respect to B cells plus medium, PWM, and IL-2 alone, the NK-induced Ig is over 10-fold higher. Although the isotype distribution is similar between unfractionated B cells and high-density B cells, the background level of Ig showed a higher variability in comparison to the high-density fraction. The NK-induced Ig response by unstimulated NK cells is similar to the B cell response reported by Cocks et al. (13) that was achieved by stimulation of purified B cells with CD40L-transfected cells. Thus, in contrast with Gray and Horwitz (22) who study the amplification by IL-2 of the NK-induced Ig synthesis, we have analyzed in greater detail this consistent B cell activation induced by unstimulated autologous NK cells to understand its possible role in the immune response.
The time curve for Ig synthesis induced by NK cells (Fig. 2) follows kinetics similar to that reported for T cell-dependent human B cell differentiation into IgM-, IgG-, and IgA-producing cells (23) . This Ig response reaches its maximum between 7 and 8 days with a plateau between 8 and 10 days of culture. Cocultures for 12 days or more showed a decrease in the accumulated Ig levels in comparison with those with 8 -10 days of incubation, due probably to an increase in the protease activity released by dead cells or generation of some other factors interfering with the ELISA cocultures of B cells with unstimulated T cells that failed to activate the B cells (data not shown). This stimulatory activity of the NK cells on the B cells was selective and specific because T cells failed to induce the B cell activation.
B cell activation by NK cells is contact-dependent
To evaluate whether activation of B cells by NK cells was contactdependent or contact-independent, we tested the activation of B cells by NK cells using transwell plates containing two chambers separated by a semipermeable membrane (polycarbonate, 0.4-um pore membrane). This membrane permits the circulation of soluble factors between both chambers but prevents B cell and NK cell contact. A fixed number of 2.5 ϫ 10 5 B cells were seeded in the lower chamber and cocultured with 5 ϫ 10 5 NK cells seeded in the upper chamber (1:2, B-NK cell ratio) for 7 days at 37°C in RPMI 1640 medium plus 10% FCS. As shown in Fig. 3 , NK cells failed to activate the B cells when cocultured in the transwell plate in comparison to those cocultured in the same plate at an identical B-NK cell ratio. These results show that activation of resting B cells by unstimulated NK cells is a cell contact-dependent process and, in contrast to mitogen-activated B cells which are induced to Ab production by NK soluble factor(s) (7), resting B cells are not inducible by NK cell soluble factors alone.
B cells primed for 5 min with NK cells progress into Igproducing cells
To evaluate whether the B cell activation required the continuous presence of the NK cells to become activated, we designed experiments of 5-min interaction between B cells and NK cells at 37°C as described in Materials and Methods. B cells were mixed at a 1:1 ratio with autologous NK cells or T cells inducing a close cell-cell contact for 5 min at 37°C. Then, the mixture was desegregated by vortexing in 1 mM of EDTA and suspended in RPMI 1640 plus 10% FCS or T cells and NK cells were depleted by magnetic columns using anti-CD3 and anti-CD56 microbeads, respectively. The number of B cells in each experimental condition (BsNK, BsT) and those cocultured together (B ϩ NK) and (B ϩ T), was adjusted to 5 ϫ 10 5 B cells/ml and cultured for 6 days at 37°C in RPMI 1640 medium containing 10% FCS. Cell-free supernatants were tested for Ig production. As shown in Fig. 4 , the B cells cocultured with NK cells (B ϩ NK mixed) and B cells stimulated 
Fixation of NK cells with glutaraldehyde abolished their stimulatory capacity
The contact-dependent cognate recognition involved in B cell activation suggested that it might require an active membrane function. Cognate interaction is an active process that requires cell membrane polarization, a phenomenon involved in many other processes, such as cell differentiation, induction of immune response, and target cell recognition and killing (24, 25) . Cell polarization is required for the conjugate formation between NK cells and their target cells (26, 27) .
To further evaluate whether the activation of B cells by NK cells requires an intact NK cell membrane mobility, we performed experiments in which the NK cell membrane was fixed with 1% glutaraldehyde before testing its capacity to stimulate B cells. Glutaraldehyde-fixed NK cells failed to activate the B cells after a (Fig. 6) or when cocultured for 6 days. These results indicate that this contact-dependent activation phenomenon is also dependent upon an active cellular membrane. Longer interaction (6 days coculture) failed to activate the B cells (data not shown). The possibility that the fixed NK cells can be deleterious for the B cell activity is unlikely because the B cells were still able to respond to fresh NK cells when cocultured for 6 days or when cocultured with fresh NK cells plus PWM (IgM ϭ 626 ng/ml; IgG ϭ 130 ng/ml; and IgA ϭ 36 ng/ml).
5-min interaction
B cell activation by NK cells is inhibited by anti-CD154 and CD40-mIg fusion protein
Numerous studies have dealt with the molecular mechanisms regulating B cell and T cell interactions, suggesting that the ligand pair CD40/CD154 plays an important role (12) . To determine whether the capacity of the NK cells to induce B cell activation was dependent on the CD40-CD154 interaction, we first cocultured both B and NK cells in the presence of different doses of anti-CD154 mAb (range: 0.1-2 g/ml). As a control for nonspecific binding via FcR, we included an identical concentration of irrelevant mouse IgG1 that matched the anti-CD154 isotype. As shown in Fig. 7 , anti-CD154 inhibited the activation of the B cells in a dose-dependent manner as demonstrated by the inhibition of IgM, IgG, and IgA synthesis.
As a second approach, we evaluated the blocking activity of CD154 and the CD40-mIg fusion protein during a short-term interaction period. B and NK cells were cocultured for 5 min at a 1:1 B-NK cell ratio in the presence of 1 g/ml anti-CD154, 1 g/ml irrelevant IgG1 isotype, 1 g/ml anti-CD56, or 100 ng/ml CD40-mIg. The B cells were separated from the NK cells as described in Materials and Methods and cultured in the absence of anti-CD154 or CD40 mIg. As shown in Fig. 8A , the presence of anti-CD154 or CD40-mIg during the B-NK interaction blocked the activation of the B cells, suggesting a critical role of the CD40-CD40L(CD154) interaction in the activation of the B cells by NK cells.
As further proof of the role of the CD40-CD154 interaction, we performed experiments involving pretreatment (1 h at 4°C) of the NK cells with 1 g/ml anti-CD154 and anti-CD56 before their use as a stimulus for the B cells at 1:1 B-NK cell ratio for 5 min. As depicted in Fig. 8B , pretreatment of NK cells with anti-CD154 abolished their capacity to activate the B cells.
Depletion of CD27
ϩ B cells and CD5 ϩ B cell subpopulations modifies the B cell response to NK cell activation As described above, the Ig response in our system is reminiscent of a secondary response in which the IgG was the main isotype in most of the donors. In addition, phenotypic analysis of our resting B cell population obtained from the high-density Percoll gradient revealed a population of 21 Ϯ 6% CD27 ϩ cells and 13 Ϯ 3% CD5 ϩ (B1) cells. From these, only 2.5 Ϯ 1% were CD27 ϩ /CD5 ϩ . To determine whether CD27 ϩ B cells and CD5 ϩ B cell subpopulations were participating in the B cell response induced by NK cells, we proceeded to deplete these B cell subsets from the tested B cell populations before their interaction with the NK cells. This approach was used due to the difficulty in isolating these B cell subsets by negative selection, avoiding the presence of Ab on the responder B cells. Purified B cells were labeled with biotinconjugated anti-CD27 ϩ , anti-CD5 ϩ , or anti-CD27 ϩ anti-CD5 mAbs and the positive cells were removed by magnetic columns using streptavidin microbeads as described in Materials and Methods. The unfractionated B cell population (total), CD27
Ϫ B cells, CD5
Ϫ B cells, and the double-negative (CD27 Ϫ CD5 Ϫ ) B cells were cocultured at 5 ϫ 10 5 cells/ml with autologous NK cells at a 1:2 B-NK cell ratio for 7 days at 37°C. Cell-free supernatants were tested for Ig synthesis.
As shown in Fig. 9 , depletion of CD27 ϩ B cells abrogated IgM synthesis induced by the NK stimulation and reduced the levels of IgG and IgA. A similar effect was also observed when the CD5 (28) . These B cell subsets in our B cell population accounted for 18 Ϯ 5% of the total B cells, while the IgG ϩ subset was 6 Ϯ 2% of the total B cells. Although the IgM ϩ IgD ϩ CD27 ϩ B cell subset represents nonactivated resting B cells, it has been shown to express higher levels of Ig mRNA than naive (IgM ϩ IgD ϩ ) B cells (29) . Thus, our results suggest that in addition to IgG ϩ B celIs, IgM ϩ IgD ϩ CD27 ϩ B cells may be responsible for the switch to an IgG isotype in our experimental system.
Discussion
The present study has investigated the interaction between human B lymphocytes and NK cells. Using highly purified human B cells and autologous NK cells, we have shown that unstimulated NK cells activate resting B cells when cocultured for 6 days at ratios of B-NK cells Ն1:1. We also demonstrate that 5 min of close contact at 37°C between both cells, followed by removal of the NK cells, was sufficient to induce the differentiation of the B cells into Igproducing cells. This activating function is contact-dependent and requires an active NK cell membrane because coculturing both cells in transwell plates or fixing the NK cell with glutaraldehyde failed to activate the B cells. Indeed, cognate interaction as a result of cell-cell conjugation has been shown to be an important feature of the interaction of B cells and NK cells (11) , a process that requires the redistribution of adhesion molecules and cell membrane polarization as demonstrated in conjugate formation of NK cells with target cells (27) . It has been shown that many membrane proteins are freely mobile and thus present an array of independent binding sites (30) . Thus, very low affinity interactions can effectively generate organized areas of synapses. Moreover, the capacity to activate resting B cells, in the absence of exogenous stimuli, is specific for NK cells, because autologous resting T cells failed to induce B cell activation. It is well known that helper T cells may activate and cooperate with B cells only after their activation using Ag receptors or by Ag-unlinked (cognate) interaction (31) . Thus, the lack of B cell activation by unstimulated T cells was expected.
Although B cell and NK cell interaction has been supported by several studies, particularly in rodent models, the experimental designs required the preactivation of the NK cells (22) or the B cells (17) . In human studies, the evidence for direct interaction of unstimulated NK cells with B cells is more limited. In a previous report, Wyatt and Dawson (11) showed that human tonsil B cells are able to conjugate to NK cells and to induce their activation and IFN-␥ production, which was suggested as a possible mediator of the Ig synthesis inhibition reported for NK cells (5, 32, 33) . However, in this study, the /ml) , anti-CD56 (1 g/ml), anti-CD154 (1 g/ml), or CD40-mIg (100 ng/ml). B, NK cells were pretreated with anti-CD154 (1 g/ml) or anti-CD156(1 g/ ml) for 1 h at 4°C before use as a stimulus for the B cells. After removal of the stimulating cells, the stimulated B, containing Ͻ2% of NK, cells were adjusted to 5 ϫ 10 5 cells/ml and cultured for 6 days at 37°C in RPMI 1640 medium plus 10% FCS. Cell-free supernatants were evaluated for Ig production. Data represent two of three independent experiments with similar results. ability of B cells to function as Ab-producing cells was not reported. In our system, the production of IFN-␥ was detected only in B cells cocultured with the NK cells (B ϩ NK), but not in the supernatant of B cells stimulated for 5 min with NK cells. This result suggests that IFN-␥ may not play a critical role. Although in our system the B cell activation is contact dependent, as demonstrated by transwell plate cultures, we cannot exclude the possibility that during the interaction (11), the NK cells produce soluble factors in the intercellular space capable of driving the B cells into Ab-producing cells. The synthesis of a late-acting soluble factor by the NK cell, which has an enhancing effect on Ig synthesis by B cells, has been hypothesized (34) . It is possible that B-NK cell interaction may reduce the B cell threshold necessary to respond to activating signals (35) . Indeed, it has been shown that activated B cells are able to synthesize and express CD40L 13 and to produce cytokines with B cell costimulatory activity. Among these cytokines, IL-6, IL-10, and TNF␣ have been shown to function as autocrine loops (36 -38) . Although in our system IL-10 was not detected in the cultures supernatant of BsNK cells, IL-6 and TNF␣ were always present.
The role of CD40-CD40L (CD154) interaction on B cell activation and differentiation has been well established for T-dependent Ab responses. However, the role of this interaction in the T-independent B cell response remains to be elucidated. In our system, B cell activation by the NK cell was inhibited by the presence of either anti-CD154 mAb or CD40-mIg fusion protein during the B-NK cell interaction or by pretreatment of the NK cells with anti-CD154 before their interaction with the B cells. This data suggests that the CD40-CD154 interaction plays an important role in this T cell-independent NK-mediated activation of B lymphocytes. The expression of CD154 on NK cells has been well-documented. Purified NK cells express mRNA for CD40L (13) and CD40L surface expression and its regulatory role on NK cell cytotoxicity have been demonstrated in IL-2-activated NK cells and NK cell lines (39) . Thus, very low levels of CD154 may be expressed constitutively on the NK cells or during the interaction with the B cells.
The possibility that activated B cells may express CD40L as suggested by Grammer et al. (40) is of functional importance in our system due to its possible contribution in homotypic B cell costimulation which, in combination with autocrine B cell factors, might drive the B cell into an Ab-producing cell. However, the possibility that CD40L acts as initiator of the B cell activation is very unlikely because purified B cells under the same interacting conditions as the B-NK cell mixture never become activated. This data suggests that contact-dependent NK cell activating signals are required.
This direct contact activation of the B cells by NK cells which, in addition to the CD40-CD40L interaction, includes the activation of cytokine production by the B cell capable of promoting its differentiation into an Ab-producing cell, is extremely important in autoimmunity and oncogenesis. In addition, increasing evidence, both in human and mouse models, has suggested an important role of NK cells in autoimmunity (20, 41) . Nevertheless, the link between the NK cell and the autoreactive B cell or transformed B cell is still missing.
In our study, the (42) . In contrast, CD5 ϩ B cells are long-lived cells that appear to be derived from precursor cells present in infant, but not in adult, bone marrow and classified as B1 cells (43) . As they arise soon after birth, they are the major source of Ab production in young individuals and might be important for T cell-independent Ab response. As they tend to produce autoreactive Igs, they have been linked to autoimmune diseases. Remarkably, the malignant cells in nearly all cases of human chronic lymphocytic leukemia carry the CD5 marker, suggesting that this malignancy arises from the CD5 ϩ B cell subset. Both, the CD27 ϩ B cells and CD5 ϩ B cell subpopulation belong to the resting B cell pool in human peripheral blood and have been implicated in the generation of natural Abs and participation in the pathophysiology of certain autoimmune diseases (20) .
This population, once activated by the NK cells, is capable of driving its own differentiation by autocrine synthesis of cytokines. To test this hypothesis, we performed depletion studies of CD27 Although 2.5% of the B cells were CD27 ϩ /CD5 ϩ , further studies are needed to elucidate this point. It is possible that after activation with the NK cells both B cell subsets require homotypic interaction to differentiate into IgM-producing cells.
As depletion of the IgG ϩ B cell subset does not significantly reduce the IgG synthesis, we postulate that another memory B cell subset with switching capacity to IgG may be involved. Recent studies (29, 42) The importance of this mechanism of B cell activation in vivo is supported by different studies. For example, the presence of NK cells in the germinal center of the human tonsil in proximity to B cells suggests a close interaction with the B cells in this lymphoid organ (44) . Secondly, NK cells could play a critical role in the initiation of an autoimmune response in combination with host intrinsic or extrinsic factors. Studies by Shi et al. (20) have shown that NK cells can affect the outcome of the adaptive immune response. NK cells, but not NK1.1 ϩ T cells, were found to participate in the development of myasthenia gravis in mice (41) . Third, the contribution of NK cells to B cell activation and differentiation in vivo has been suggested from human bone marrow transplantation (BMT). In recipients of T cell-depleted allogeneic bone marrow transplants, large granular lymphocytes which contain mostly NK cells were found responsible for the secretion of B cell differentiation factors capable of maintaining the Ig expression and specific Ab levels in the absence of mature T cells. It appears likely that NK cells play a significant role in maintaining B cell function in vivo upon T cell-depleted BMT (10, 45) . Donor type-activated NK cells have also been shown to promote BMT in mice (9) .
The establishment of a link between NK cells, autoreactive B cells, and circulating memory B cells in our study also suggests a potential regulation by NK cells of the adaptive immune response through their direct interaction with cells and the production of a number of immunoregulatory factors. NK cells might provide an advantage to the host before the development of specific and potent helper T cells. The extension of our findings into animal models should allow further testing of these hypotheses.
